What We Inherit, and What We Pass On Without Choosing
What We Inherit, and What We Pass On Without Choosing
As a kid, I had an odd fondness for ants and spiders. The ants faded with time. The spiders never did.
When one turns up in the house now, my wife and daughter yell for someone to kill it, and I catch myself hoping it survives the day.
What holds me is the web. The tidy spiral kind everyone pictures. The trapdoor kind too, silk strung like a trip-wire over a burrow in the ground. Every species builds its own pattern, and not one of them was ever taught how.
So what, exactly, is sitting inside a gene that no one explained to it?
A middle-aged man carefully rescues a house spider while sunlight illuminates a delicate spider web, symbolizing the mystery of DNA and inherited instinct.
A White House Genome Announcement That Wasn't Finished
That question, what genetic inheritance actually hands down and what it leaves out, turns out to have a much stranger history than a spiderweb.
On the morning of June 26, 2000, President Bill Clinton stood in the East Room of the White House to announce that scientists had produced a working draft of the human genome. Prime Minister Tony Blair joined by satellite from London. Francis Collins, head of the National Human Genome Research Institute, spoke for the public international project. Craig Venter spoke for Celera Genomics, the private company racing to the same finish line.
Genetic inheritance is the passing of DNA-based instructions from parents to offspring through egg and sperm cells. It shapes family resemblance and disease risk, was famously mapped by the Human Genome Project, and has since been reshaped again by direct gene-editing treatments, though it still leaves personality and identity largely unexplained.
What the announcement celebrated wasn't a finished genome. The public project had assembled overlapping fragments spanning 97 percent of the genome and sequenced 85 percent of it. Celera, meanwhile, was set to describe its own first assembly at a 12:30 p.m. press conference the same day. The day marked a landmark working draft, not a final book.
Reading the transcript now, what strikes me is how carefully Collins and Venter both kept saying "survey" and "working draft" instead of "finished" — a caution that mostly didn't survive contact with the headlines that followed.
That day reads like the moment inheritance stopped being a private matter and became a national project, something a president could stand up and announce the way you'd announce a bridge finished, or a war won.
Scientists and government leaders announce the Human Genome Project draft at the White House, marking a milestone in human genetics research.
Before It Was a Public Project, Heredity Was Used as a Weapon
Long before that East Room ceremony, the idea of heredity had already been put to a far uglier use in the United States.
Indiana passed the nation's first compulsory sterilization law in 1907. It didn't come off the books until 1974, recent enough that some of today's grandparents lived through it as adults.
At least 60,000 Americans were sterilized without consent by the 1970s under laws active in 30 states, according to the National Human Genome Research Institute's own history of the period. The people targeted were disproportionately Latino, Native American, Black, poor white, and disabled.
Reading through the actual statute language for this piece, what unsettled me wasn't a single monstrous line. It was how procedural all of it reads, filed and administered like any other government program.
The people running those programs weren't reading anyone's actual genes; the science didn't exist yet to do that. One way to see it: what those laws actually tracked was stigma, poverty, disability, being the wrong kind of poor, dressed up in the language of heredity because it sounded scientific.
Maybe the real lesson isn't that heredity is dangerous. It's that whoever gets to define what counts as a defect holds more power than any single gene ever could.
Historical illustration of the American eugenics movement showing how genetic science was once misused to justify forced sterilization policies.
What Actually Gets Passed Down, Cell by Cell
None of that explains the actual mechanics: how a trait gets from one generation into the next in the first place.
MedlinePlus, the National Library of Medicine's public reference, puts it plainly. A typical human cell carries 46 chromosomes in 23 pairs, one chromosome in each pair from the biological mother, the other from the father.
Meiosis, the process that builds eggs and sperm, cuts that number from 46 down to 23. When an egg and a sperm combine at fertilization, the count returns to 46, but not as a clean copy of either parent.
Picture two matching chromosomes lying side by side as a cell prepares to divide, swapping stretches of DNA before they pull apart. That crossover is a routine part of why a child's chromosomes usually arrive as a reshuffled mix rather than an untouched copy of either parent's.
I tried explaining crossover to my son once with two decks of playing cards, shuffling a few from each together before dealing out a new hand. It's the closest analogy I've found — and the only one that's ever gotten him to stop nodding politely and actually look interested.
Geneticists measure it in centimorgans: one centimorgan is roughly a 1 percent chance of recombination separating two genetic markers during a single meiosis.
That's part of why a child can look strikingly like a parent to everyone else and not at all to himself in the mirror. The traits people are best at spotting in someone else's face are often the hardest to see in their own, and the gap between a photo and a mirror is its own small proof of that.
Traits like height and skin color don't follow Mendel's simple dominant-recessive math at all. They come from many genes acting together, plus environment, which is why two full siblings can share both parents and still turn out different in ways no single inherited "rule" explains.
Looked at this way, a spider's inherited blueprint and a human one aren't as different as they first sound. Both are instructions copied forward, recombined, and expressed without the animal ever being consulted.
Scientific visualization of DNA recombination during meiosis as chromosomes exchange genetic material to create unique human inheritance.
One "Complete" Genome Still Wasn't Everyone's Genome
The 2000 announcement wasn't actually the end of the reading, either.
The Human Genome Project called itself "essentially complete" in 2003. That hedge got flattened by the headlines, mine included, which reported it as finished outright. But even the project's own careful wording covered a working reference spanning about 92 percent of the genome, not every last stretch of DNA.
In 2022, the Telomere-to-Telomere Consortium published T2T-CHM13: a gapless sequence, roughly 3.055 billion base pairs, covering every human chromosome except Y. It closed the old reference's remaining gaps, adding about 200 million base pairs, 1,956 predicted genes, and 99 likely protein-coding ones.
The gaps in the 2022 reference genome were finally closed. The gap in whose ancestry it represented was not.
A reference genome works like a photograph, standing in for more people than it depicts, the way one picture can outlive the person in it. CHM13 makes that literal in an odd way. The cell line behind it is nearly homozygous throughout, useful for assembly precisely because it isn't an ordinary person's mix of two distinct parents. What ancestry it does carry traces mostly to Northern Europe. That's part of why 2023 brought Han1: a gapless assembly from an actual Southern Han Chinese individual, representing the kind of population CHM13 was never built to cover.
It's tempting to size up your own ancestry against "the" reference genome the way people size up a neighbor's house. That habit of comparison doesn't hold up with genomes, either.
The honest read: completeness and representation turned out to be two different jobs, and finishing one didn't finish the other.
Modern genetic researchers using CRISPR gene-editing technology inside an advanced biomedical laboratory focused on disease treatment.
From Reading Genes to Editing Them
By the time gene editing became a real treatment rather than a lab technique, the question had shifted again: not what a genome says, but what a doctor is allowed to change in it.
The World Health Organization's 2021 governance framework draws a hard line through human genome editing: changing a patient's own cells is one thing, changing an embryo is another. The first treats one person. The second could introduce a change that may be inherited by future generations, which is exactly why the WHO singled out heritable editing for separate international oversight.
So does editing a patient's blood cells mean their children inherit the fixed version of a gene, too? Not with Casgevy.
The FDA approved it in December 2023 for sickle cell disease patients twelve and older with recurrent vaso-occlusive crises — the first CRISPR-based treatment cleared for use in the United States. It works by modifying hematopoietic stem cells taken from the patient's own body, not the reproductive cells that would pass anything forward.
Reading about Casgevy, I keep coming back to a strange comfort in that distinction: whatever gets fixed in one person's blood stays with that person, at least for now. Inheritance, for once, isn't part of the deal.
Somatic editing like this had already treated conditions including HIV and transthyretin amyloidosis before Casgevy's approval, according to the WHO's own account of the field. Heritable editing, the kind that would change future generations, remains a separate and far more heavily governed question. The WHO has continued tracking it through an international registry into 2024.
It's hard not to see this as inheritance's next real turn. For most of human history, no one could touch what got passed down. Now, for at least one disease, someone finally can, just not yet for whoever comes after.
| Year | Genome | What Changed |
|---|---|---|
| 2003 | Human Genome Project reference sequence declared "essentially complete" | Became the working reference used for the next two decades |
| 2022 | T2T-CHM13 (Telomere-to-Telomere Consortium) | Filled the remaining gap, adding about 200 million base pairs |
| 2023 | Han1 (Southern Han Chinese genome) | A gapless, reference-quality assembly from a Southern Han Chinese individual |
My son resembles me in more than his face. I catch pieces of my own temperament in him before he's even old enough to know he has one. I recognize the same thing looking backward: a way of thinking I trace straight to my father, even a color I can't quite explain preferring.
Maybe a spider is born already knowing how to build the exact web its species has always built, and something similar is happening in us, just quieter and harder to name. Genetic inheritance may not stop at a face or a body. This isn't something science can measure, but I like to think it shapes how a person comes to look at the world, long before anyone taught them to.
A father and son walking beneath a glowing spider web and DNA helix at sunset, representing inherited traits passed through generations.
Sources & References
- National Human Genome Research Institute: June 2000 White House Event
- National Human Genome Research Institute: Eugenics and Scientific Racism
- National Human Genome Research Institute: Human Genome Project Fact Sheet
- PubMed / NCBI: Telomere-to-Telomere genome completion and representation research
- PMC / G3 Genes|Genomes|Genetics: The First Gapless, Reference-Quality, Fully Annotated Genome From a Southern Han Chinese Individual (Han1)
- MedlinePlus (National Library of Medicine): Chromosomes
- World Health Organization: Human Genome Editing governance framework
- U.S. Food and Drug Administration: FDA Approves First Gene Therapies to Treat Patients with Sickle Cell Disease
Comments
Post a Comment